Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical development of vascular disrupting agents: what lessons can we learn from ASA404?

× No keyword cloud information.

11 in total

1. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.

Authors: Junjie Li; Min Zhou; Fengyong Liu; Chiyi Xiong; Wanqin Wang; Qizhen Cao; Xiaoxia Wen; J David Robertson; Xin Ji; Y Andrew Wang; Sanjay Gupta; Chun Li
Journal: Radiology Date: 2016-06-27 Impact factor: 11.105

Review 2. Natural products against cancer angiogenesis.

Authors: El Bairi Khalid; El-Meghawry El-Kenawy Ayman; Heshu Rahman; Guaadaoui Abdelkarim; Agnieszka Najda
Journal: Tumour Biol Date: 2016-09-20

3. A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).

Authors: Marc C Chamberlain; Sean Grimm; Surasak Phuphanich; Larry Recht; Jay Z Zhu; Lyndon Kim; Steve Rosenfeld; Camilo E Fadul
Journal: J Neurooncol Date: 2014-04-17 Impact factor: 4.130

Review 4. B cell MHC class II signaling: A story of life and death.

Authors: Divya Sai Katikaneni; Lei Jin
Journal: Hum Immunol Date: 2018-04-30 Impact factor: 2.850

Review 5. Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.

Authors: Ahmed M Al-Abd; Abdulmohsin J Alamoudi; Ashraf B Abdel-Naim; Thikryat A Neamatallah; Osama M Ashour
Journal: J Adv Res Date: 2017-06-27 Impact factor: 10.479

6. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.

Authors: Bonan Zhao; Zhipeng Dong; Weixing Liu; Fangning Lou; Qiyan Wang; Hao Hong; Yue Wang
Journal: J Nanobiotechnology Date: 2021-05-01 Impact factor: 9.429

7. Phenotype-based Discovery of 2-[(E)-2-(Quinolin-2-yl)vinyl]phenol as a Novel Regulator of Ocular Angiogenesis.

Authors: Alison L Reynolds; Yolanda Alvarez; Temitope Sasore; Nora Waghorne; Clare T Butler; Claire Kilty; Andrew J Smith; Carmel McVicar; Vickie H Y Wong; Orla Galvin; Stephanie Merrigan; Janina Osman; Gleb Grebnev; Anita Sjölander; Alan W Stitt; Breandán N Kennedy
Journal: J Biol Chem Date: 2016-02-04 Impact factor: 5.157

8. Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways.

Authors: Ali S Arbab; Meser M Ali
Journal: Nov Approaches Cancer Study Date: 2020-05-29

9. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.

Authors: Charlene M Downey; Mehrnoosh Aghaei; Reto A Schwendener; Frank R Jirik
Journal: PLoS One Date: 2014-06-18 Impact factor: 3.240

Review 10. Advances in targeted and immunobased therapies for colorectal cancer in the genomic era.

Authors: Heng Fong Seow; Wai Kien Yip; Theodora Fifis
Journal: Onco Targets Ther Date: 2016-03-31 Impact factor: 4.147